- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on WT1 Positive in Korea, Democratic People's Republic of
Total 334 results
-
Boryung Biopharma Co., Ltd.UnknownPertussis | Tetanus | Diphtheria | PoliomyelitisKorea, Republic of
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedChronic Myeloid LeukemiaUnited States, Belgium, France, Korea, Republic of
-
Bolt Biotherapeutics, Inc.Bristol-Myers SquibbActive, not recruitingHER2-positive Breast Cancer | HER2-positive Colorectal Cancer | HER2-positive Solid Tumors | HER2-positive Gastroesophageal Cancer | HER2-positive Endometrial CancerFrance, United States, Spain, Korea, Republic of, Italy
-
Rajaie Cardiovascular Medical and Research CenterNational Institute for Medical research and Development (NIMAD); Abidi PharmaceuticalsTerminatedAtrial Fibrillation | Rheumatic Heart Disease | Mitral Stenosis | Anticoagulant Adverse ReactionIran, Islamic Republic of
-
Kyoto Breast Cancer Research NetworkPfizerCompletedHormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer FemaleTaiwan, Japan, Korea, Republic of, Australia, Hong Kong
-
Hoffmann-La RocheActive, not recruitingAnaplastic Lymphoma Kinase-positive Non-small Cell Lung CancerChina, Korea, Republic of, Thailand
-
University of CologneUnknownStaphylococcus Aureus BacteremiaUnited Kingdom, Spain, Taiwan, Korea, Republic of, Germany
-
Novartis PharmaceuticalsCompletedAdvanced HER2-positive Breast Cancer or Gastric CancerTaiwan, Netherlands, Italy, United States, Belgium, United Kingdom, Korea, Republic of, France, Spain
-
CinnagenCompletedHER2-positive Breast CancerIran, Islamic Republic of
-
Foundation for Innovative New Diagnostics, SwitzerlandCompletedTuberculosis | Drug-resistant TuberculosisGeorgia, Germany, India, Moldova, Republic of, South Africa
-
McGill UniversityCanadian Institutes of Health Research (CIHR)CompletedLatent Tuberculosis InfectionCanada, Australia, Benin, Brazil, Ghana, Indonesia, Guinea, Korea, Republic of, Saudi Arabia
-
GlaxoSmithKlineCompletedTetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type bKorea, Republic of
-
SPP Pharmaclon Ltd.RecruitingRespiratory TuberculosisRussian Federation
-
Otsuka Pharmaceutical Development & Commercialization...CompletedTuberculosis, Pulmonary | Extensively Drug-Resistant Tuberculosis | Tuberculosis, Multidrug ResistantKorea, Republic of, China, United States, Egypt, Estonia, Japan, Latvia, Peru, Philippines
-
German Breast GroupPfizer; AGO Study Group; Breast International Group; NSABP Foundation IncCompletedBreast Cancer | Hormonreceptor Positive | Her2-normal | Postneoadjuvant Treatment With CDK 4/6 Inhibitor | CPS-EG ScoreUnited States, Australia, Austria, Canada, France, Germany, Ireland, Japan, Korea, Republic of, Spain, United Kingdom
-
Sanofi Pasteur, a Sanofi CompanyCompletedHepatitis B | Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b InfectionKorea, Republic of
-
Merck Sharp & Dohme LLCCompletedPneumococcal InfectionsUnited States, Korea, Republic of, Spain, Taiwan
-
Il-Yang Pharm. Co., Ltd.RecruitingChronic Myeloid Leukemia, Chronic Phase | CML, Chronic Phase | CML, Refractory | CML - Philadelphia ChromosomeTurkey, Korea, Republic of, Russian Federation, Ukraine
-
Novartis PharmaceuticalsActive, not recruitingALK Positive MalignanciesChina, United States, Italy, Taiwan, Australia, Belgium, Germany, Spain, Czechia, Japan, Russian Federation, Korea, Republic of, Hong Kong, France, Lebanon, Malaysia, Brazil, Poland, Bulgaria, Colombia, Singapore
-
Research Center BorstelLudwig-Maximilians - University of MunichTerminatedBacterial Infections | Tuberculosis, Pulmonary | Tuberculosis, Multidrug-Resistant | Mycobacterial InfectionGermany, Moldova, Republic of, Romania, Ukraine
-
Il-Yang Pharm. Co., Ltd.CompletedHematologic Diseases | Leukemia | Leukemia, Myeloid | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Philadelphia ChromosomeIndia, Korea, Republic of, Thailand
-
PfizerCompletedPneumococcal DiseaseKorea, Republic of, Taiwan, Japan
-
Janssen Infectious Diseases BVBACompletedTuberculosisChina, Ukraine, Korea, Republic of, Peru, Estonia, Kenya, Latvia, Philippines, Russian Federation, South Africa, Thailand, Turkey
-
HI-BioCompletedGlomerulonephritis | Membranous Nephropathy | antiPLA2R PositiveTaiwan, Korea, Republic of, Greece, Germany, United Kingdom, Georgia, Russian Federation
-
AmgenTerminatedMUC17-positive Solid TumorsUnited States, Korea, Republic of, Taiwan, Spain, Austria, France, Japan, Germany, Netherlands
-
Yale UniversityNational Institute on Drug Abuse (NIDA); Ukrainian Institute on Public Health... and other collaboratorsActive, not recruitingDepression | HIV Infections | Hepatitis B | Hepatitis C | Tuberculosis | Opioid-use Disorder | SyphilisKyrgyzstan, Moldova, Republic of, Ukraine
-
IUATLD, IncMedical Research Council; Institute of Tropical Medicine, Belgium; Liverpool... and other collaboratorsCompletedMDR-TBEthiopia, Georgia, India, Moldova, Republic of, Mongolia, South Africa, Uganda
-
Novartis PharmaceuticalsRecruitingMyeloid Leukemia, Philadelphia PositiveKorea, Republic of, Germany, France, Greece, Hungary, Italy, Japan, Russian Federation, Thailand, Turkey, China, United States, Netherlands, Poland
-
Bristol-Myers SquibbCompletedChronic Phase Chronic Myeloid LeukemiaFrance, Italy, United States, Korea, Republic of, Germany
-
Bill & Melinda Gates Medical Research InstituteActive, not recruitingTuberculosis, PulmonarySouth Africa, Bangladesh, Brazil, India, Indonesia, Mozambique, Zambia, Congo, The Democratic Republic of the, Gambia, Kenya, Peru, Philippines, Uganda, Vietnam
-
Novartis PharmaceuticalsCompletedChronic Myelogenous Leukemia | Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaGermany, Australia, Netherlands, Spain, Korea, Republic of, France, Japan, Italy, Singapore, United States
-
PfizerCompletedSystemic Anaplastic Large-Cell Lymphoma | Non-Small Cell Lung Cancer ALK-positive | Non-Small Cell Lung Cancer c-Met Dependent | Non-Small Cell Lung Cancer ROS Marker Positive | Advanced Malignancies Except LeukemiaUnited States, Korea, Republic of, Australia, Japan
-
Kartos Therapeutics, Inc.RecruitingChronic Myeloid LeukemiaItaly, Spain, United States, Korea, Republic of, France, Poland, Canada, Russian Federation
-
Hoffmann-La RocheRecruitingInoperable, Locally Advanced or Metastatic, ER-positive Breast CancerUnited States, Korea, Republic of, Spain, Australia, Israel
-
University of California, San FranciscoJohns Hopkins UniversityNot yet recruitingTuberculosis, Pulmonary | Tuberculosis, Multidrug-Resistant | Tuberculosis, MDRPeru, Vietnam, Moldova, Republic of, Mongolia, Pakistan, Philippines, South Africa
-
Novartis PharmaceuticalsCompletedPhiladelphia Positive (Ph+) Chronic Myelogenous LeukemiaUnited States, France, Korea, Republic of, Thailand, Italy, Netherlands, Turkey, Hungary, Russian Federation, Spain, United Kingdom, Japan, Malaysia
-
Merck Sharp & Dohme LLCCompletedPneumococcal InfectionUnited States, Australia, Canada, Chile, Japan, Korea, Republic of, New Zealand, Poland
-
AstraZenecaParexelCompletedEGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerSpain, United States, Italy, Korea, Republic of, Malaysia
-
Turnstone Biologics, Corp.TakedaTerminatedRenal Cell Carcinoma | Cervical Cancer | Solid Tumor | Mesothelioma | Melanoma (Skin) | Oropharynx Cancer | HPV Positive Oropharyngeal Squamous Cell Carcinoma | Microsatellite Stable Colorectal Cancer | Cutaneous Squamous Cell CarcinomaUnited States, Canada, Korea, Republic of
-
Hoffmann-La RocheRecruitingALK Fusion-positive Solid or CNS TumorsUnited States, Korea, Republic of, China, Spain, Canada, Australia, United Kingdom, Denmark, France, Italy, Germany, Brazil
-
Synta Pharmaceuticals Corp.CompletedBreast Cancer | Triple Negative Breast Cancer | HER-2 Positive Breast Cancer | ER/Progressive Response (PR) + Refractory to Prior Hormonal TreatmentSpain, United States, Argentina, Belgium, Brazil, Korea, Republic of, Peru, United Kingdom
-
Eli Lilly and CompanyCompletedHER-2 Positive Breast Cancer | Hormone Receptor Positive Breast CancerSpain, United States, Korea, Republic of, Belgium, France, Germany, Italy, Australia, Argentina, Canada, United Kingdom, Mexico, Brazil, Greece
-
Enliven TherapeuticsRecruitingChronic Myeloid LeukemiaUnited States, Spain, France, Germany, Korea, Republic of, Australia, Canada
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, Pulmonary | Tuberculosis, Multidrug-Resistant | Extensively Drug-Resistant Tuberculosis | Tuberculosis, MDR | XDR-TB | Pre-XDR-TBSouth Africa, Russian Federation, Georgia, Moldova, Republic of
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMultidrug-resistant TuberculosisSouth Africa, Estonia, Philippines, Peru, Lithuania, Latvia, Moldova, Republic of
-
TakedaTerminatedNarcolepsy Type 1 (NT1) | Narcolepsy Type 2 (NT2)China, United States, Korea, Republic of, France, Italy, Finland, Spain, Czechia, Canada, Japan, Hungary, Netherlands
-
Queen Mary University of LondonAstraZenecaUnknownEstrogen Receptor Positive Breast CancerSpain, United Kingdom, France, Portugal, Georgia, Korea, Republic of, Germany, Hungary, Romania
-
PfizerCompletedALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLCUnited States, Canada, Australia, Taiwan, Singapore, Japan, Korea, Republic of, Spain, Belgium, Switzerland, France, Germany, Hong Kong, Italy
-
CytomX TherapeuticsCompletedNeoplasms | Breast Cancer | Breast Neoplasms | Breast Neoplasms, Triple-Negative | Breast Neoplasms, Hormone Receptor Positive/HER2 NegativeUnited States, Spain, Korea, Republic of
-
HI-BioCompletedTrial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) (M-PLACE)Glomerulonephritis, Membranous | antiPLA2R PositiveSpain, Belgium, Australia, Italy, United States, Korea, Republic of, France, Netherlands, Poland